Nonetheless, the CD44+ CSC-like cells continue to be significantly enriched in the hypoxic (EGFP+) population of tumor cells ex vivo from 2nd xenografts derived from either EGFP+ or EGFP− MCF7 cells (Fig. 5b). This evidence concerns the gene CD44 and neoplasm.